rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2006-6-12
|
pubmed:abstractText |
Optimizing oral therapy in patients with unstable decompensated and/or dobutamine-dependent congestive heart failure (CHF) is a challenge.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0167-5273
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
28
|
pubmed:volume |
110
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
313-7
|
pubmed:dateRevised |
2008-3-25
|
pubmed:meshHeading |
pubmed-meshheading:16099518-Adult,
pubmed-meshheading:16099518-Aged,
pubmed-meshheading:16099518-Dose-Response Relationship, Drug,
pubmed-meshheading:16099518-Female,
pubmed-meshheading:16099518-Follow-Up Studies,
pubmed-meshheading:16099518-Growth Hormone,
pubmed-meshheading:16099518-Heart Failure,
pubmed-meshheading:16099518-Humans,
pubmed-meshheading:16099518-Male,
pubmed-meshheading:16099518-Middle Aged
|
pubmed:year |
2006
|
pubmed:articleTitle |
Beneficial effects of high doses of growth hormone in the introduction and optimization of medical treatment in decompensated congestive heart failure.
|
pubmed:affiliation |
Heart Failure Clinics of the Clinical Cardiology Department, Heart Institute of the São Paulo University Medical School, Brazil. dcledimar@incor.usp.br
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|